BankPlus Trust Department’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.56M Buy
12,589
+1,112
+10% +$381K 1.07% 18
2026
Q1
$4.04M Sell
11,477
-1,107
-9% -$395K 1.08% 13
2025
Q4
$4.12M Buy
12,584
+924
+8% +$293K 1.08% 14
2025
Q3
$3.29M Sell
11,660
-3
-0% -$870 0.88% 25
2025
Q2
$3.26M Buy
11,663
+3,425
+42% +$970K 0.96% 18
2025
Q1
$2.57M Buy
8,238
+254
+3% +$75K 0.86% 24
2024
Q4
$2.08M Buy
+7,984
New +$2.37M 0.68% 29

Other funds holding AMGN

BankPlus Trust Department's AMGN Position: Q2 2026 in Review

BankPlus Trust Department increased its Amgen (AMGN) stake by 9.7% in Q2 2026, buying an estimated $381K and bringing the position to 12,589 shares worth $4.56M. The position accounts for 1.07% of the portfolio, ranked #18.

BankPlus Trust Department first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,293 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • BankPlus Trust Department held 12,589 shares of Amgen worth $4.56M as of Q2 2026.
  • BankPlus Trust Department bought 1,112 Amgen shares in Q2 2026, an estimated $381K.
  • Amgen made up 1.07% of BankPlus Trust Department's portfolio in Q2 2026, its #18 holding.
  • BankPlus Trust Department first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 1,293 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on BankPlus Trust Department's 13F filing for Q2 2026, filed 28 Jul 2026.